blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3463427

EP3463427 - METHODS AND COMPOSITIONS FOR THE TREATMENT OF SECRETORY DISORDERS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  17.05.2024
Database last updated on 24.08.2024
FormerThe application is deemed to be withdrawn
Status updated on  26.03.2021
FormerRequest for examination was made
Status updated on  08.03.2019
FormerThe international publication has been made
Status updated on  02.12.2017
Most recent event   Tooltip29.07.2024New entry: Additional fee for renewal fee: payment of fee 
29.07.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Board of Regents, The University of Texas System
201 West 7th Street
Austin, TX 78701 / US
[2019/15]
Inventor(s)01 / MANGELSDORF, David, J.
201 West 7th Street
Austin TX 78701 / US
02 / KLIEWER, Steven, A.
201 West 7th Street
Austin TX 78701 / US
03 / COATE, Katie, C.
201 West 7th Street
Austin TX 78701 / US
04 / HERNANDEZ, Genaro
201 West 7th Street
Austin TX 78701 / US
 [2019/15]
Representative(s)Lee, Nicholas John
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2019/15]Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
Application number, filing date17803516.824.05.2017
[2019/15]
WO2017US34288
Priority number, dateUS201662341591P25.05.2016         Original published format: US 201662341591 P
[2019/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017205517
Date:30.11.2017
Language:EN
[2017/48]
Type: A1 Application with search report 
No.:EP3463427
Date:10.04.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 30.11.2017 takes the place of the publication of the European patent application.
[2019/15]
Search report(s)International search report - published on:US30.11.2017
(Supplementary) European search report - dispatched on:EP11.02.2020
ClassificationIPC:A61K38/18, C07K14/50, A61P1/18
[2020/11]
CPC:
A61K38/1825 (EP,IL,US); A61K38/18 (IL); A61K9/0019 (IL,US);
A61K9/0053 (IL,US); A61P1/18 (EP,IL,US); C07K14/50 (EP,IL,US)
Former IPC [2019/15]A61K38/18, C07K14/50
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/15]
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON SEKRETORISCHEN ERKRANKUNGEN[2019/15]
English:METHODS AND COMPOSITIONS FOR THE TREATMENT OF SECRETORY DISORDERS[2019/15]
French:MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DE TROUBLES SÉCRÉTOIRES[2019/15]
Entry into regional phase17.12.2018National basic fee paid 
17.12.2018Search fee paid 
17.12.2018Designation fee(s) paid 
17.12.2018Examination fee paid 
Examination proceduredeletedDeletion: Application deemed to be withdrawn, date of legal effect  [2024/25]
deletedDate on which the examining division has become responsible
17.12.2018Examination requested  [2023/51]
03.09.2020Amendment by applicant (claims and/or description)
01.12.2020Application deemed to be withdrawn, date of legal effect  [2021/17]
22.12.2020Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/25]
24.10.2023Date of oral proceedings
10.11.2023Minutes of oral proceedings despatched
05.12.2023Despatch of a communication from the examining division (Time limit: M04)
05.04.2024Reply to a communication from the examining division
Request for re-establishment of rights:26.03.2021Date of receipt
Fees paidRenewal fee
27.11.2019Renewal fee patent year 03
26.03.2021Renewal fee patent year 04
09.11.2023Renewal fee patent year 05
09.11.2023Renewal fee patent year 06
09.11.2023Renewal fee patent year 07
29.07.2024Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.05.201903   M06   Fee paid on   27.11.2019
31.05.202004   M06   Fee paid on   26.03.2021
31.05.202408   M06   Fee paid on   29.07.2024
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO03011213  (LILLY CO ELI [US], et al) [X] 1,6-15 * abstract * * page 3, line 21 - line 27 *;
 [X]WO2011154349  (NOVO NORDISK AS [DK], et al) [X] 1,6-15 * abstract * * page 1, line 4 - line 8 *;
 [X]WO2012066075  (NOVARTIS AG [CH], et al) [X] 1,6-15 * abstract * * paragraphs [0001] , [0010] , [0068] , [0069] , [0225] *;
 [X]US2012172298  (ANDERSEN BIRGITTE [DK], et al) [X] 1,6-15 * abstract * * paragraphs [0006] , [0251] *;
 [X]  - Y. C. WOO ET AL, "Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives", CLINICAL ENDOCRINOLOGY, (20130312), vol. 78, no. 4, doi:10.1111/cen.12095, ISSN 0300-0664, pages 489 - 496, XP055125055 [X] 1,6-15 * abstract *

DOI:   http://dx.doi.org/10.1111/cen.12095
 [I]  - JOHNSON C L ET AL, "Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice", GASTROENTEROLOGY : OFFICIAL PUBLICATION OF THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION, WILLIAMS & WILKINS, US, vol. 137, no. 5, doi:10.1053/J.GASTRO.2009.07.064, ISSN 0016-5085, (20091101), pages 1795 - 1804, (20090805), XP026701655 [I] 1-15 * Conclusions *

DOI:   http://dx.doi.org/10.1053/j.gastro.2009.07.064
 [XP]  - COATE KATIE C ET AL, "FGF21 Is an Exocrine Pancreas Secretagogue", CELL METABOLISM, CELL PRESS, UNITED STATES, (20170112), vol. 25, no. 2, doi:10.1016/J.CMET.2016.12.004, ISSN 1550-4131, pages 472 - 480, XP029914127 [XP] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/j.cmet.2016.12.004
International search[A]US2013079500  (BOETTCHER BRIAN R [US], et al) [A] 1-20 * entire document *;
 [A]US2013129724  (BOETTCHER BRIAN R [US], et al) [A] 1-20* entire document *;
 [A]US2015284442  (LING LEI [US], et al) [A] 1 -20 * entire document *;
 [X]WO2015195509  (NGM BIOPHARMACEUTICALS INC [US]) [X] 1, 6-8 * entire document *;
 [X]WO2016065106  (NGM BIOPHARMACEUTICALS INC [US]) [X] 1-5, 9-20 * entire document *;
 [A]WO2016065326  (BRISTOL MYERS SQUIBB CO [US]) [A] 1-20 * entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.